Kritika Agarwal speaks to The Hindu Business Line on indemnity for vaccine makers

by | Aug 24, 2021

Kritika Agarwal, Associate Partner – Corporate/M&A and Competition spoke to The Hindu Business Line on Indemnity for vaccine makers. According to her, “vaccine manufacturers may not want to spend time and money on defending any claims in all the countries where they supply and be subject to extensive litigation.”

Read the full article here.

More News

Benchmark Litigation Rankings 2022

We are pleased to announce that Majmudar & Partners has been recognised by Benchmark Litigation Asia-Pacific 2022. Neerav Merchant, Partner and Head of Disputes, has been named as a Litigation Star for the practice area of Commercial and Transactions. The firm has...

read more